Chris Garabedian on Sarepta’s legacy and Biogen’s future at the FDA
The former Sarepta CEO talks about the controversy that surrounded the company’s first Duchenne drug and what he’s been up to since then.
Related Articles
How California, now an epicenter for bird flu in dairy cattle, is monitoring the virus
California now has more bird flu-infected cattle herds than any other U.S. state.
2024 STAT Summit
The STAT Summit is back in Boston October 16 & 17, 2024 — this year we’re examining change in medicine, why it’s so hard, &…
With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit
Calley and Casey Means have gotten the attention of conservative media with their views of a flawed health care system.
White House should declare national emergency over IV fluid shortages caused by Helene, says hospital group
With a Baxter plant shuttered by Hurricane Helene, the AHA asked the White House to declare an IV fluid shortage and invoke national emergency powers.
12 people changing the course of the Chinese biopharma industry
Here is a list of top figures to watch in China’s biopharma industry.
How California, now an epicenter for bird flu in dairy cattle, is monitoring the virus
California now has more bird flu-infected cattle herds than any other U.S. state.
2024 Nobel Prize winner Gary Ruvkun on sharing credit and the future of microRNA
Nobel winners Gary Ruvkun and Victor Ambros discovered microRNA, which has been used to study cancer treatments, diabetes, and metabolism.
2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA
Two scientists who discovered a type of RNA molecule that helps control the activity of genes have won the 2024 Nobel Prize in medicine.
Wealthy nations might be reaching a life expectancy limit, study suggests — at least for now
Life expectancy gains have substantially slowed in wealthier nations, which appear to be nearing a limit to improvements
The 2024 Medicine Nobel, and remembering Sammy Basso
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Why do bad menstrual cramps happen to